Sign in
4

Changes in Ownership

Maze Therapeutics, Inc. Filed Acc 0001192591-26-000004

Options or other derivatives

  • Director acquired 18,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
HOMCY CHARLES J Director 2026-06-08 Grant or award · Stock Option (Right to Buy) +18,000 18,000 D
Loading xslF345X06/form4-06102026_080626.xml…